In this blog, NCI’s Center for Cancer Health Equity, Dr. Laritza Rodriguez, looks at one technique to help counter a lack of diversity in your data set. See how Synthetic Minority Oversampling Techniques (SMOTE) can help bring your biomedical research data into better balance.
The OncoAlert Newsletter is now out for June 23-29, 2023
AbstractBaseline cardiovascular assessment before the initiation of potentially cardiotoxic cancer therapies is a key component of cardio-oncology, aiming to reduce cardiovascular complications and…
NOMINATE The Giants of Cancer Care ® program, presented by OncLive ®, recognizes and celebrates the individuals who have achieved landmark successes within the global…
The FDA has approved ensartinib for patients with ALK+ locally advanced or metastatic NSCLC who have not previously received an ALK inhibitor.
The OncoAlert Newsletter is now out for June 23-29, 2023
The Lymphoma Research Foundation (LRF) offers a wide range of support services, for people with lymphoma and their loved ones.
A new ancestry-adjusted risk prediction model, Genomic-informed Care for Motivating High Risk Individuals Eligible for Evidence-based Prevention (GREAT), may aid patients in decision-making around lung…
SEER*Explorer provides access to SEER cancer statistics and detailed statistics for a cancer site by gender, race, calendar year, age, and for a selected number…
